GPT and liver disorder: We excluded patients with ALT or AST > 5 times the ULN prior starting Remdesivir, known HBV, HDV & HCV or any known liver disease, eGFR < 30 ml/min so more studies with larger sample size would be beneficial to evaluate the effect of Remdesivir in these group of patients in more detail.